Life Spine enters the Chinese market

Singapore: Life Spine, a medical device company dedicated to improving the quality of life for spinal patients has made...

May 26, 2014 | Monday | News
Linaclotide phase III trial initiated in China

Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...

September 11, 2013 | Wednesday | News
China to expand list of price-controlled drugs

Singapore: China is set to increase the number of products on its price-controlled "essential drugs" list. Report from R...

August 21, 2012 | Tuesday | Regulatory
Stephen Young is HitGen's new VP of BD

Singapore: HitGen, a rapidly developing lead generation services company in the global biopharmaceutical industry, has ...

January 18, 2013 | Friday | News
Bangalore gets medical quality assesment lab

Singapore: CSA Group, global testing and certification service provider with operations in China, has launched a testing...

April 24, 2013 | Wednesday | News
Sinopharm to build China's largest R&D center

Singapore: Sinopharm Group is going to build China's largest Biotechnology Research Institute in Wuhan East Lake High-te...

August 7, 2013 | Wednesday | News
Healthcare evolution is fuelled by silicon tech

To get an idea of how much silicon technology will impact healthcare and wellness, we just need to look at how semicondu...

February 25, 2013 | Monday | Opinion
Obesity an epidemic in developing countries'

Singapore: Out of 2.1 billion obese population in the world, 15 percent are the Indians and Chinese, reveals a study con...

April 24, 2013 | Wednesday | News
India, China to witness high growth of multiple sclerosis in 10 yrs: GlobalData

Singapore: Market analysis firm, GlobalData, reports that among counries including US, Canada, France, Germany, Italy, S...

May 20, 2014 | Tuesday | Analysis
Pharma companies set eyes on China

China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. Th...

June 19, 2012 | Tuesday | Analysis
Alnylam and Ascletis collaborate to develop RNAi liver cancer therapeutic

Singapore: Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have formed a strategic collaboration for the developmen...

July 13, 2012 | Friday | News
Calgary Scientific expands into China

Singapore: Calgary Scientific, a company known for creating transformative technology, is continuing to revolutionize gl...

July 19, 2012 | Thursday | News
WuXi, OMT join hands to develop OmniRat antibodies

Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing com...

September 5, 2012 | Wednesday | News
Korean, Chinese firms sign depression drug deal

Singapore: South Korean-based SK Biopharmaceuticals entered into a collaboration agreement with PKU International Health...

April 2, 2013 | Tuesday | News
Del Mar, Guangxi Wuzhou join hands for cancer drug

Singapore: Del Mar Pharmaceuticals announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical, a subsidiary...

October 30, 2012 | Tuesday | News
Pusey is new president, GM of WuXiPRA China

Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and g...

July 17, 2013 | Wednesday | News
What the future holds for the APAC CRO market?

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
joimax goes BRIC and beyond

Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emergi...

April 24, 2012 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls